Overview
  • Transaction Name: Merck & Co., Inc. / Prometheus Biosciences, Inc.
  • Acquirer: Merck & Co., Inc.
  • Target: Prometheus Biosciences, Inc.
  • Announcement Date: April 16, 2023
  • Status: Pending
Loading...
  • of